Skip to main content
Vasilis Ntziachristos
Helmholtz Munich | ©Stephan Rumpf

Dr. Vipul Gujrati

Our goal is the development of intelligent nanomedicine solutions for theranostic challenges.

Our goal is the development of intelligent nanomedicine solutions for theranostic challenges.


Dr. Vipul Gujrati is a Research Group Leader at the Institute of Biological and Medical Imaging (IBMI) of Helmholtz Munich, Germany. He started his postdoctoral research career under the mentorship of Professor Vasilis Ntziachristos in the fields of Optoacoustic imaging and Theranostics, with a particular emphasis on nano agents for bio-imaging and drug delivery applications.  For the last five years, Dr. Gujrati has been mentoring graduate students and leading different projects, including the European Commission’s H2020 research. Dr. Gujrati holds a Ph.D. in Biological Sciences from the Korea Advanced Institute of Science and Technology (KAIST), South Korea, specialising in Biomaterials and Synthetic materials for imaging and drug delivery applications. He holds a Master’s in Pharmacology and toxicology from the Rajiv Gandhi University of Health Sciences (RGUHS), Karnataka, India, and a Bachelor’s degree in Pharmacy from the University of Pune, Maharashtra, India. Dr. Gujrati’s work has led to advances in a number of areas, including biomaterials, cell therapy, drug and vaccine delivery, gene therapy, material science, biophotonics, and optoacoustic imaging, and has resulted in high-impact publications. He received the Scientific Excellence Award from CBI-IBMI in 2019, and the Best Thesis Award (Gold Medal) from KAIST in 2014 for his outstanding work demonstrating the applicability of nanomaterials for cancer imaging and therapy.

Fields of Work and Expertise

BiomarkersBiomaterialsContrast agentsDrug deliveryNanomedicinesOptoacousticsOptoacousticsDetections & MonitoringTheranosticsCancerMetabolic DiseasesInflammatory diseasesHyperthermiaRegenerative TherapyImmunotherapy

Professional Background


Group Leader: Institute of Biological and Medical Imaging (IBMI), Helmholtz Zentrum München (HMGU); Munich, Germany.


Postdoctoral fellow (Project lead): Chair for Biological Imaging (CBI), Technical University Munich (TUM), Munich, Germany.


Postdoctoral fellow: Department of Biological Science, Korea Advanced, Institute of Science and Technology (KAIST), Daejeon, South Korea.

03/2010 - 08/2014

Ph.D. Biological Science: Korea Advanced Institute of Science and Technology (KAIST), Daejeon, South Korea. (Supervisor: Prof. Sangyong Jon)

07/2006 - 01/2008

Research scientist: Torrent Pharmaceuticals LTD, Gandhinagar, India.

03/2004 - 05/2006

Master of Pharmacy: Pharmacology and Toxicology, Rajiv Gandhi University of Health Sciences (RGUHS), Bangalore, India.

Honors and Awards

Recipient of IBMI/CBI 2019 award for Scientific Excellence, Technical University Munich
(TUM) and Helmholtz Munich
Recipient of best thesis award (Gold medal), Korea Advanced Institute of Science and
Technology (KAIST)
Recipient of a graduate scholarship from Korea Advanced Institute of Science and Technology and Gwangju Institute of Science and Technology



Liu N, Gujrati V, Najafabadi JM, Werner JPF, Klemm U, Tang L, Chen Z, Prakash J, Huang Y, Stiel A, Mettenleiter G, Aichler M, Blutke A, Walch A, Kleigrewe K, Razansky D, Sattler M, Ntziachristos V. Croconaine-based nanoparticles enable efficient optoacoustic imaging of murine brain tumors. Photoacoustics, 2021, Vol. 22, 100263, ISSN 2213-5979.

Gujrati V, Prakash J, Najafabadi JM, Stiel AC, Klemm U, Mettenleiter G, Aichler M, Walch A, Ntziachristos V. Bioengineered bacterial vesicles as biological nano-heaters for optoacoustic imaging. Nature Communications. 2019, 10, 1114.

Gujrati V, Mishra A, Ntziachristos V. Molecular imaging probes for multi-spectral optoacoustic tomography. Chemical Communications. 2019, 53 (34), 4653-4672.

Gujrati V, Lee M, Ko YJ, Lee S, Kim D, Kim HJ, Kang SM, Lee SY, Kim JJ, Jeon H, Kim SC, Jun YS, and Jon S. Bioengineered yeast-derived vacuoles with enhanced tissue penetrating ability for targeted cancer therapy. Proceedings of the National Academy of Sciences of the United States of America. 2016; 19; 113 (3):710-5.

Gujrati V, Kim S, Kim SH, Min JJ, Choy HE, Kim SC and Jon S. Bioengineered bacterial outer membrane vesicles as cell-specific drug-delivery vehicles for cancer therapy. ACS Nano. 2014; 8(2), 1525-1537.


Technical University of Munich, Ludwig-Maximilians-Universität, TOMI- NUIG, REMEDI-NUIG, DIMES-University of Genoa, DIMI- University of Genoa, University of Cambridge, ETH Zurich, KAIST, KRICT, CUG China, IISc, IIT Karagpur.

Affiliations: Helmholtz Munich (Research Scientist) and TUM (Visiting Researcher)